2024-517875-19-00RecruitingPhase 1
A pilot study to assess the impact of ABCB1 on the neuropharmacokinetics of the weak ABCB1 substrate [11C]metoclopramide
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 85 (estimated)
- First submitted
- 21 Nov 2024
- Start date
- 12 Oct 2017
- Lead sponsor
- Medical University Of Vienna
- Diseases
- Alzheimer disease
- EU CT number
- 2024-517875-19-00
- EudraCT number
- 2017-000989-30
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 85
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Vienna | Vienna | Austria | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.